Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer
NCT01444521
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
irinotecan and cisplatin
Sponsor
Chinese Academy of Medical Sciences